E-52862

E-52862 is a selective sigma receptor agonist that is currently under investigation for its potential use in the treatment of pain. It was developed by the Spanish pharmaceutical company Esteve.

Pharmacology

E-52862 interacts with sigma receptors, specifically the sigma-1 receptor. Sigma receptors are a unique class of intracellular receptors that have been implicated in a variety of biological functions, including neuroplasticity, neuroprotection, and the modulation of neurotransmission.

Clinical Trials

E-52862 has undergone Phase I and Phase II clinical trials for the treatment of pain. The results of these trials have shown that E-52862 is well-tolerated and has a favorable safety profile. Further studies are needed to fully understand the therapeutic potential of this drug.

See Also

• Sigma receptor
• Selective sigma receptor agonist
• Esteve (company)

References

E-52862 Resources
Need Help Finding a Doctor? Need help finding a doctor or specialist anywhere in the world? Explore our world directory. WikiMD's DocFinder can assist you in locating millions of physicians.	Medical Knowledge Access the latest research - Most recent articles Ongoing trials.

Translate to: East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski